iiinova — where your digital self keeps evolving

holoclara.bsky.social @holoclara.bsky.social · 02/07/2025

In The Scientist’s Innovation Spotlight Q&A, our CEO Andrea Choe reveals how Holoclara is pioneering a new frontier in drug discovery by harnessing nature’s symbiotic species, starting with molecules derived from worms. 🪱💊 Read the full feature 👇 www.the-scientist.com/turning-worm...

the-scientist.com

Turning Worm-Derived Molecules into Life-Changing Therapies

Andrea Choe from Holoclara discusses her quest to develop novel drugs for chronic immune conditions by mining nature’s immunomodulators.

000

holoclara.bsky.social @holoclara.bsky.social · 22/05/2025

Today we recognize the 1st World Eosinophilic Esophagitis (EoE) Day! We’re raising awareness and reaffirming our commitment to pioneering treatments for underserved patients through the therapeutic potential of worms! 🪱 Learn more: www.holoclara.com #NEAW #EosAware

000

holoclara.bsky.social @holoclara.bsky.social · 13/05/2025

On AUTM on the Air, our CEO Andrea Choe shared insights on Holoclara’s work harnessing worm-derived molecules for medicine, along with her experiences collaborating with tech transfer offices at @caltech.edu and @cornelluniversity.bsky.social. 🎧 Listen now: www.youtube.com/watch?v=TZIy...

youtube.com

Turning Worms Into Medicine: Dr. Andrea Choe on Innovation, Impact, and Tech Transfer

YouTube video by AUTM

000

holoclara.bsky.social @holoclara.bsky.social · 22/04/2025

Worms were long overlooked—now they could help transform human health. 🪱 Our CEO Andrea Choe, shared the science behind our discovery engine and its potential to access other untapped sources with In Vivo Citeline. Read more 👇 tinyurl.com/4vr8sp96

tinyurl.com

Building The Worm Atlas For I&I Breakthroughs

The next big thing in auto-immune therapies: worms. Or so a young California biotech believes. Holoclara is pioneering a new class of medicines derived from intestinal worms to revolutionize the treat...

000

holoclara.bsky.social @holoclara.bsky.social · 15/04/2025

How might the “dark matter” of biology unlock new medicines? 🌌 Labiotech’s must-read explainer covers the rise of metabolomics as a critical tool for decoding biology, featuring insights from our CEO Andrea Choe. Check it out 👇 www.labiotech.eu/in-depth/met...

labiotech.eu

The metabolomics revolution: Why biotech leaders should pay attention

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate biotech research.

000

holoclara.bsky.social @holoclara.bsky.social · 11/03/2025

In an @asbmb.bsky.social interview, CEO Andrea Choe shared how treating patients inspired her shift from medicine to entrepreneurship, founding Holoclara to bring relief to millions suffering from debilitating diseases – by harnessing molecules from worms. 🪱 Read more 👇 www.asbmb.org/asbmb-today/...

asbmb.org

Biotech startup worms its way into therapeutics

Andrea Choe's company, Holoclara, has created an anti-inflammatory drug based on a molecule from worms.

032

holoclara.bsky.social @holoclara.bsky.social · 21/02/2025

Great to be featured in Labiotech’s Best in Biotech series! Check out their article to learn how we’re decoding biology through metabolomics to pioneer worm-derived therapies: www.labiotech.eu/best-biotech...

labiotech.eu

Seven companies using metabolomics to decode biology

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

000

holoclara.bsky.social @holoclara.bsky.social · 08/02/2025

Great to see our CEO Andrea Choe on stage at Caltech's Merkin Institute Symposium where she shared insights from founding Holoclara amongst fellow entrepreneurs, scientists, and leaders.💡

000

holoclara.bsky.social @holoclara.bsky.social · 01/02/2025

🎧On the latest @InVivoPodOnX episode, our CEO Andrea Choe discussed the incredible therapeutic potential of gut-dwelling roundworms and Holoclara's work harnessing worm-derived molecules to treat devastating disorders. Tune in now 👇 youtu.be/dJluLzQ67K4?...

youtu.be

Ep. 16 | In Vivo with Dr. Andrea Choe On The Gut Worm Revolution

YouTube video by In Vivo Podcast

000

holoclara.bsky.social @holoclara.bsky.social · 18/12/2024

We’re pleased to announce our first-in-human Phase 1 clinical trial of HC002 – a novel worm-derived medicine – and eosinophilic esophagitis (EoE) as our lead indication. Check out our video and press releases below for more on HC002 and EoE ⬇️

100